Clinical research news in brief
August 24, 2011Research and Development contract research news, research and development news
Private equity firm the Carlyle Group is rumoured to be looking at buying PPD, plus there are updates from CTA/Clininvent, …
AZ details US doctor payments
August 24, 2011Sales and Marketing AstraZeneca, industry reputation, payments
AstraZeneca is shining a light on its activities in the US, disclosing for the first time how much it pays …
Spain to cut 2.4 billion euros from drugs bill with new generics rules
August 24, 2011Sales and Marketing Spain, generic prescribing, generics
The Spanish government has passed new laws to increase generic prescribing and cut billions of euros from the country’s drugs …
Blood cancer drug Adcetris approved by FDA
August 24, 2011Sales and Marketing Adcetris, Cancer, Seattle Genetics, lymphoma
The FDA has approved Seattle Genetics’ blood cancer drug Adcetris for two forms of lymphoma. Adcetris (brentuximab vedotin) can now …
Quintiles appoints Troy Norris to head up consulting group
August 24, 2011Research and Development appointment, research and development
Troy Norris has joined Quintiles as vice president and managing director for the product development and commercialisation practice at its …
UK research receives £800m funding boost
August 23, 2011Research and Development NIHR, UK research, UK science, research and development news
Research into dementia, cancer, diabetes and heart disease are among the activities to benefit from a new £800 government funding …
Zaicom Medical Marketing Communications appoints Ana Gaskill
August 23, 2011Medical Communications appointment, medical communications
Zaicom Medical Marketing Communications (Zaicom MMC) has appointed Ana Gaskill as an account director. She joins the West Sussex, UK-based …
Healthcare communications – how to influence behaviour change
August 23, 2011Medical Communications communications, healthcare communications
For decades, healthcare communications has used a fixed way of approaching patients and customers. But now we must adopt new …
FDA fast tracks Bayer prostate cancer drug
August 23, 2011Sales and Marketing Algeta, Alpharadin, Bayer, prostate cancer
Bayer’s potential blockbuster prostate cancer drug Alpharadin has been granted a fast track review by the FDA, meaning it could …
NICE blames Faslodex rejection on uncertainties in AZ data
August 23, 2011Sales and Marketing AstraZeneca, Faslodex, NICE, breast cancer
NICE has not recommended a high-dose form of AstraZeneca’s breast cancer drug Faslodex because of uncertainties over its cost-effectiveness. In …
GSK invests in UK biotech start-up
August 22, 2011Research and Development Autifony, GSK, biotech, hearing loss, research and development news
GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …
Generic user fees could boost FDA inspection powers
August 22, 2011Manufacturing and Production Mylan, generics, pharma manufacturing news
Generic drugmakers have forged a tentative deal with the US government that could see user fees being used to help …
BMS launches skin cancer treatment Yervoy in UK
August 22, 2011Sales and Marketing Yervoy, cancer vaccine, ipilimumab, skin cancer
Bristol-Myers Squibb’s skin cancer treatment Yervoy has been launched in the UK for patients with the deadliest form of the …
Double Helix expands strategic market research team
August 22, 2011Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing
Global market research consultancy Double Helix has appointed Fiona Bailey and Anwar Kumi to the positions of associate director and …
J&J’s latest recall put down to new factor
August 19, 2011Manufacturing and Production J&J, JJ, Tylenol, recalls
Yet another Johnson & Johnson recall has been announced, but this time the perpetrator doesn’t feature among the ‘usual suspects’. …
Pharma manufacturing news in brief
August 19, 2011Manufacturing and Production pharma manufacturing news
Lonza launches a stripped down material supply service for biologics developers, plus facility news from United Therapeutics, Dr Reddy’s and …
EMA to review two new Pfizer cancer drugs
August 19, 2011Sales and Marketing Cancer, Pfizer, bosutinib, crizotinib
The EMA has accepted Pfizer’s regulatory submissions for two of its new cancer compounds. The first is its much-lauded crizotinib, …
Idea Pharma boosts project management team
August 19, 2011Sales and Marketing appointment, sales and marketing
Phase II strategy consultancy Idea Pharma has appointed two new project managers to its team – Suzanne Axford-Bryars and Lidia …
OPEN Health launches research service
August 19, 2011Medical Communications Open Health, medical communications agency
Healthcare communications agency OPEN Health, has launched OPEN Plan, a market research and brand planning specialist team. The company says …
Roche’s Zelboraf approved by FDA months ahead of schedule
August 18, 2011Sales and Marketing Yervoy, Zelboraf, skin cancer
The FDA has approved Roche and Daiichi Sankyo’s new skin cancer drug Zelboraf two months ahead of schedule. Zelboraf (vemurafenib) …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
